SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000920465-19-000147
Filing Date
2019-10-18
Accepted
2019-10-18 16:47:17
Documents
1
Period of Report
2019-10-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_157143159782782.html 3  
1 FORM 3 wf-form3_157143159782782.xml 3 1708
  Complete submission text file 0000920465-19-000147.txt   3103
Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address HALOZYME THERAPEUTICS, INC. 11588 SORRENTO VALLEY ROAD, #17 SAN DIEGO CA 92121
Business Address
RAMSAY DAVID A (Reporting) CIK: 0001283292 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36282 | Film No.: 191158219